{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:38:00Z","timestamp":1790030280327,"version":"4.0.1"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"},{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2649059","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:42:08Z","timestamp":1774021328000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65\u201384\u2009years of age in Belgium: An epidemiological modeling study"],"prefix":"10.1080","volume":"22","author":[{"given":"Yannick","family":"Vandenplas","sequence":"first","affiliation":[{"name":"MSD Belgium & Luxembourg","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Dobbelaere","sequence":"additional","affiliation":[{"name":"MSD Belgium & Luxembourg","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleana","family":"Tsoumani","sequence":"additional","affiliation":[{"name":"MSD Greece","place":["Alimos, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Oidtman","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lang","sequence":"additional","affiliation":[{"name":"Merck Canada Inc","place":["Kirkland, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Meleleo","sequence":"additional","affiliation":[{"name":"Wolfram Research, Inc","place":["Champaign, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Sharomi","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"European Centre for Disease Prevention and Control. Factsheet for health professionals about pneumococcal disease. [accessed 2025 Mar 10]. https:\/\/www.ecdc.europa.eu\/en\/pneumococcal-disease\/facts."},{"key":"e_1_3_6_3_1","volume-title":"Manual for the surveillance of vaccine-preventable diseases","author":"Gierke R","year":"2020","unstructured":"Gierke R, McGee L, Beall B, Pilishivili T. Pneumococcal disease. In: Roush SW, Baldy LM, editors. Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention; 2020."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2014.19.31.20869"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.057"},{"key":"e_1_3_6_6_1","unstructured":"National Reference Center (NRC) for Streptococcus pneumoniae (invasive). Annual reports: NRC invasive Streptococcus pneumoniae (2018-2024). 2024. https:\/\/www.sciensano.be\/en\/nrc-nrl\/national-reference-center-nrc-streptococcus-pneumoniae-invasive."},{"key":"e_1_3_6_7_1","doi-asserted-by":"crossref","unstructured":"Blommaert A Hanquet G Willem L Theeten H Thiry N Bilcke J Verhaegen J Beutels P. Use of pneumococcal vaccines in the elderly: an economic evaluation. Health technology assessment (HTA). Vol. KCE reports 274Csh. 2016. https:\/\/kce.fgov.be\/sites\/default\/files\/2021-11\/KCE_274C_Short-Report_Pneumococcal.pdf.","DOI":"10.57598\/R274CS"},{"key":"e_1_3_6_8_1","unstructured":"Sciensano. For a healthy Belgium: non-communicable diseases: overview. [accessed 2025 Mar 10]. https:\/\/www.healthybelgium.be\/en\/health-status\/non-communicable-diseases\/overview."},{"key":"e_1_3_6_9_1","unstructured":"Statbel. Structure of the population. [accessed 2025 Mar 10]. https:\/\/statbel.fgov.be\/en\/themes\/population\/structure-population."},{"key":"e_1_3_6_10_1","unstructured":"Federal Planning Bureau. Population outlook for Belgium: the older population is growing faster than the working-age population. [accessed 2025 Feb 5]. https:\/\/www.plan.be\/en\/publications\/population-outlook-belgium-older-population."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-022-00097-y"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111338"},{"key":"e_1_3_6_13_1","unstructured":"Groupe Vaccination du Conseil Sup\u00e9rieur de la Sant\u00e9. Vaccination antipneumococcique. 2014. https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/19100960\/Vaccination%20antipneumococcique%20-%20adultes%20%282014%29%20%28CSS%209210%29.pdf."},{"key":"e_1_3_6_14_1","unstructured":"Hoge Gezondheidsraad. Vaccinatie tegen pneumokokken (volwassenen). [accessed 2025 Feb 5]. https:\/\/www.hgr-css.be\/nl\/advies\/9674\/vaccinatie-tegen-pneumokokken-volwassenen."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2005.050"},{"key":"e_1_3_6_16_1","unstructured":"Superior Health Council (of Belgium). Vaccination against pneumococcal disease in adults. 2025. https:\/\/www.hgr-css.be\/file\/download\/fd947263-b70f-4a88-88e9-8bc4ccd13e74\/o5vSEEl5uAuHLfZUQlzs0w3rMdCE3i8TwfyLM8yUhk3d.pdf."},{"issue":"11","key":"e_1_3_6_17_1","first-page":"665","article-title":"Pneumococcal vaccination among at-risk groups with comorbidities: guidelines from the \u201cBelgian Superior Health Council\u201d and reimbursement criteria","volume":"78","author":"Scheen A","year":"2023","unstructured":"Scheen A, Louis R, Lancellotti P, Jouret F, Delwaide J, Moutschen M. Pneumococcal vaccination among at-risk groups with comorbidities: guidelines from the \u201cBelgian Superior Health Council\u201d and reimbursement criteria. Rev Med Liege. 2023;78(11):665\u2013673. Vaccination antipneumococcique dans les groupes a risque avec comorbidites : recommandations du Conseil Superieur de la Sante et criteres de remboursement.","journal-title":"Rev Med Liege"},{"key":"e_1_3_6_18_1","unstructured":"European Medicines Agency. Capvaxive: pneumococcal polysaccharide conjugate vaccine (21-valent). [accessed 2025 Jun 2]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/capvaxive."},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00526-6"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400108"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01111-8"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050475"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126985"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-020-00250-7"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.11.24308671"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15939-7"},{"key":"e_1_3_6_28_1","unstructured":"Centre National de R\u00e9f\u00e9rence des Pneumocoques. Rapports\/publications. [accessed 2025 June 12]. https:\/\/cnr-pneumo.com\/rapports-publis."},{"key":"e_1_3_6_29_1","unstructured":"Hoge Gezondheidsraad. Basic immunisation schedule. Recommended by the Superior Health Council (June 2021). [accessed 2025 Apr 4]. https:\/\/www.hgr-css.be\/en\/report\/9606\/basic-immunisation-schedule."},{"key":"e_1_3_6_30_1","unstructured":"Sciensano. Jaarraport VPD 2021: vaccinatiegraad. [accessed 2025 Jul 8]. https:\/\/www.sciensano.be\/sites\/default\/files\/vaccine_coverage_2020-21_nl_final.pdf."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2273892"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.012"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.011"},{"key":"e_1_3_6_34_1","unstructured":"World Health Organization. Who bacterial priority pathogens list 2024: bacterial pathogens of public health importance to guide research development and strategies to prevent and control antimicrobial resistance. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"e_1_3_6_35_1","doi-asserted-by":"crossref","unstructured":"Gerkens S Lef\u00e8vre M Bouckaert N Levy M de Noordhout CM Obyn C Devos C Scohy A Vlayen A Yaras H et al. Performance of the Belgian health system: report 2024. Vol. KCE reports 376C. 2024. https:\/\/kce.fgov.be\/en\/performance-of-the-belgian-health-system-report-2024.","DOI":"10.57598\/R376C"},{"key":"e_1_3_6_36_1","volume-title":"Draft council conclusions on the improvement of cardiovascular health in the European Union","author":"Council of the European Union","year":"2024","unstructured":"Council of the European Union. Draft council conclusions on the improvement of cardiovascular health in the European Union. Vol. 15315\/24. 2024. https:\/\/data.consilium.europa.eu\/doc\/document\/ST-15315-2024-INIT\/en\/pdf."},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487314549512"},{"key":"e_1_3_6_38_1","unstructured":"Vlaamse Regering. Vernieuwde gezondheidsdoelstelling vaccinatie. [accessed 2025 May 15]. https:\/\/www.vlaanderen.be\/vlaamse-regering\/beslissingen-van-de-vlaamse-regering\/vernieuwde-gezondheidsdoelstelling-vaccinatie."},{"key":"e_1_3_6_39_1","unstructured":"Statistiek Vlaanderen. Zorg en ondersteuning voor ouderen. [accessed 2025 Sep 10]. https:\/\/www.vlaanderen.be\/statistiek-vlaanderen\/zorg\/zorg-en-ondersteuning-voor-ouderen."},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2022.100589"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2649059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:42:11Z","timestamp":1774021331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2649059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2649059"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2649059","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2649059"}}